Skip to content

Quantitative dual-tracer 18F-FDG and 18F-DPA-714 PET/MR for characterizing pathological subtypes in refractory mesial temporal lobe epilepsy.

Aug 2026 · European Journal of Nuclear Medicine and Molecular Imaging · 0 citations · 31 references
Medicine

TL;DR

Dual-tracer PET/MR combined with quantitative analysis may improve subtype-specific presurgical localization in refractory MTLE, whereas FDG-PET facilitated differentiation of pathological subtypes.

View source

Similar papers

Sep 2026

Clinical outcomes of dynamic [18F]-FDG PET in focal epilepsy: a prospective early observational study.

BACKGROUND AND PURPOSE Standard static 18F-fluorodeoxyglucose PET (sPET) frequently registers normal metabolism in patients with focal drug-resistant epilepsy (DRE), limiting its utility for identifying the epileptogenic zone (EZ) for epilepsy surgery. Dynamic FDG-PET (dPET), which quantifies the rate of glucose uptake...

M. Quigg, P. Chernyavskiy, William Terrell et al. · 0 citations
Open access Oct 2026

Utility and limitations of 18F-fluciclovine PET for biopsy targeting in a nonenhancing diffuse glioma with a gliomatosis cerebri–like growth pattern: illustrative case

Contrast-enhanced MRI reflects blood-brain barrier (BBB) disruption rather than tumor biological activity, whereas 18 F-fluciclovine ( 18 F-FACBC) PET reflects amino acid metabolism independent of BBB integrity. The authors compared regional 18 F-FACBC uptake with histopathological and molecular findings in...

Soma Matsueda, Nayuta Higa, Ryutaro Makino et al. · 0 citations
Open access Sep 2026

18F-FDG PET/CT metabolic patterns and clinical parameters correlate with disease severity in autoimmune encephalitis

To investigate the correlation of 18 F-FDG PET/CT metabolic patterns and clinical parameters with disease severity in patients with autoimmune encephalitis (AE). We retrospectively analyzed 35 AE patients who underwent 18 F-FDG PET/CT at the Second Affiliated Hospital of Soochow University between...

Bao-Cheng Liu, Ning Wang, Wei-Wei Kong et al. · 0 citations
Sep 2026

Distinct Spatiotemporal Patterns of Dopaminergic and Metabolic Imaging in De Novo Parkinson's Disease.

BACKGROUND Understanding the heterogeneity of Parkinson's disease (PD) is essential to guide patient care, prognosis, and treatment. OBJECTIVE We used 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET), 18F-N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane (18F-FP-CIT) PET, and Subtype...

Jung Hyun Lee, H. K. Na, Sung Jun Ahn et al. · 0 citations
Open access Aug 2026

Dynamic Metabolic Parameters and Deauville Score on 18F-FDG PET/CT for Prognostic Assessment in Pediatric Burkitt Lymphoma

Highlights What are the main findings? The %ΔSUVmax and the end-of-treatment Deauville score predicted survival in pediatric Burkitt lymphoma. Baseline SUVmax, MTV, and TLG showed only modest, estimated prognostic value in this cohort. What are the implications of the main findings? Dynamic metabolic response may be a...

E. Isık, Ş. Şahin, D. Şimşek et al. · 0 citations
Open access Aug 2026

Comparative Performance of 18F-FDG PET/CT and 68Ga-FAPI PET/CT in TENIS Syndrome in Treated Differentiated Thyroid Carcinoma.

Objectives Thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome presents a significant diagnostic challenge in the management of differentiated thyroid carcinoma (DTC). Although 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is the established imaging modality f...

Jayantilal Bhagirath Bhad, Manjit Sarma, U. Menon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.